Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas

Oncology Reports

Volumn 4, Issue 1, 1997, Pages 157-159

  Lissom, Paolo ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Immunotherapy; Interleukin 2; Melatonin; Soft tissue sarcomas

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 2; MELATONIN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031037680     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Mulé JJ, Shu S, Schwarz SL and Rosenberg SA: Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225: 1487-1489, 1984.
2. Rosenberg SA: The immunotherapy and gene therapy of cancer. J Clin Oncol 10: 180-199, 1992.